Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112409115B discloses a novel aryl silane route for trifluoromethylthio compounds, offering high selectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN116730813A reveals a safer Grignard route for 4,4'-Difluorobenzophenone. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1164557C reveals a halogen exchange method improving purity to 97% and yield to 91% for deltamethrin production. This advanced agrochemical intermediate process ensures stable supply chain continuity and substantial cost reduction for global buyers.
Patent CN107266283B introduces a novel diacyl peroxide method for Heck reactions. Achieve high-purity pharmaceutical intermediates with reduced costs and scalable supply chains.
Patent CN117003647A details a Ru-Co alloy catalyst for low-temperature reductive amination, offering high yield and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN87105804A details a novel route for L-carnitine intermediates, offering cost reduction in pharma manufacturing and reliable supply chain solutions.
Patent CN106699507B details water-based hydrogenation for high-purity alpha-phenylethanol. This green process ensures supply chain reliability and significant cost reduction.
Patent CN103641731B reveals a high-yield synthesis route for phenylacetamide derivatives. Discover cost-effective manufacturing and supply chain advantages for agrochemical intermediates.
Patent CN101993398B details a green catalytic hydrogenation method for 1,8-diamino-3,6-naphthalene disulfonic acid, offering high purity and eliminating iron sludge waste for reliable supply.
Patent CN101798272A enables high-purity p-aminoanisole via supercritical CO2 hydrogenation, offering cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN117229316A reveals copper-catalyzed synthesis for high-purity organophosphine intermediates. Enables cost reduction and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN103044287B reveals mild room temperature synthesis for diaryl urea compounds ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Patent CN108409784B reveals a cost-effective route for phosphochiral intermediates using PCl3, offering reliable supply chain solutions for high-purity ligand precursors.
Advanced palladium catalyzed synthesis enables efficient production of high purity MOF ligands ensuring supply chain stability and cost reduction for global pharmaceutical partners
Advanced solid-catalyst synthesis of Octanoyl Hydroxamic Acid (CAS 7377-03-9). Enhancing purity and sustainability for pharmaceutical and cosmetic intermediate manufacturing.
Novel biomass-derived route for polyamide intermediates. Reduces energy and waste via catalytic hydroformylation and carbonylation technology.
Patent CN111423315A details a mild Pd-catalyzed Suzuki coupling for 2-arylacrolein diacetals, offering superior yield and scalability for pharmaceutical intermediate manufacturing.
Novel patent CN113801152B offers high purity 99.8% route. Cost-effective pharma intermediate manufacturing with scalable supply chain solutions.
Patent CN111270260A introduces a green electrochemical Rh-catalyzed alkenylation method, offering cost reduction and scalable solutions for fine chemical manufacturing.
Patent CN103319368A reveals a phosphine-catalyzed route offering high yield and mild conditions. This breakthrough ensures cost reduction and supply chain stability for agrochemical manufacturing.